ArticleTherapeutic advances in medical oncology2022

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study.

Foteinos-Ioannis Dimitrakopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.